Auxotrophic Mycobacterium bovis BCG: Updates and Perspectives

Mycobacterium bovis BCG has been used for a century as the only licensed vaccine against tuberculosis. Owing to its strong adjuvant properties, BCG has also been employed as an oncological immunotherapeutic as well as a live vaccine vector against other pathogens. However, BCG vaccination has limite...

Descripción completa

Detalles Bibliográficos
Autores principales: Dellagostin, Odir Antônio, Borsuk, Sibele, Oliveira, Thaís Larré, Seixas, Fabiana Kömmling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146772/
https://www.ncbi.nlm.nih.gov/pubmed/35632558
http://dx.doi.org/10.3390/vaccines10050802

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146772/
https://www.ncbi.nlm.nih.gov/pubmed/35632558
http://dx.doi.org/10.3390/vaccines10050802

Ejemplares similares